Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  DietMedicationType 2 DiabetesPrediabetesIssue 700

High Magnesium Intake May Offset Risk of Developing Diabetes

Magnesium intake may be particularly beneficial in offsetting risk of developing diabetes among those at high risk....
Advertisement

In this study, Hurby et al examined 7-yr associations between magnesium intake and the incidence of prediabetes and/or insulin resistance, and progression from these states to type 2 diabetes. A total of 2,582 participants ages 26–81 years old at baseline were selected. Magnesium intake and risk of metabolic impairment, defined as impaired fasting glucose (≥5.6–<7.0 mmol/L), impaired glucose tolerance (2-hr postload glucose ≥7.8–<11.1 mmol/L), insulin resistance, or hyperinsulinemia (≥90th percentile of HOMA-IR or fasting insulin, respectively), was estimated among those with normal baseline status. The risk of incident diabetes was estimated among those with baseline metabolic impairment. In participants without incident diabetes, the authors examined magnesium intake in relation to 7-yr changes in fasting and postload glucose and insulin, insulin resistance, and insulin sensitivity.

After adjusting for age, sex, and energy intake, compared to those with the lowest magnesium intake, those with the highest intake had 37% lower risk of incident metabolic impairment. For those with baseline metabolic impairment, higher intake was associated with a 32% lower risk of incident diabetes. In the combined population, the risk in those with the highest intake was 53% compared to those with the lowest intake of magnesium. Adjusting for risk factors and dietary fiber attenuated associations in the baseline normal population, but did not substantially affect associations in the metabolically impaired.

Higher magnesium intake tended to associate with lower follow-up fasting glucose and IR, but not fasting insulin, postload values, or insulin sensitivity. As a result, the authors concluded that magnesium intake may be particularly beneficial in offsetting risk of developing diabetes among those at high risk.

Practice Pearls:
  • Magnesium intake may be particularly beneficial in offsetting risk of developing diabetes among those at high risk.
  • Those with the highest intake had 37% lower risk of incident metabolic impairment.

Diabetes Care, October 2013 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 25 October, 2013 and appeared in  DietMedicationType 2 DiabetesPrediabetesIssue 700

Past five issues: Diabetes Clinical Mastery Series Issue 212 | GLP-1 Special Editions October 2014 | Issue 752 | SGLT-2 Inhibitors Special Edition October 2014 | Diabetes Clinical Mastery Series Issue 211 |

2014 Most Popular Articles:

For Your Patients: Why Daily Movement Improves Your Brain Health (Part 2): Brain Hormone Changes
Posted October 17, 2014
Two Positive Phase 3 Trials for ITCA 650, a GLP-1 Agonist, in Type 2 Diabetes
Posted October 10, 2014
Adding an SGLT2 to Insulin Improved Control
Posted October 17, 2014
New GLP-1 Receptor Agonist as an Alternative to Insulin Glargine?
Posted October 10, 2014
Vitamin D and Type 2 Diabetes Risk
Posted October 17, 2014
Best Insulin Regimen for Type 1's
Posted October 10, 2014
EASD: Insulin Pumps Lower Mortality Rate 29% Compared to Multiple Injections in T1DM
Posted October 03, 2014
Handbook of Diabetes, 4th Ed., Excerpt #13: Control and Complications
Posted October 13, 2014
Non-Caloric Artificial Sweeteners May Induce Glucose Intolerance
Posted October 10, 2014
FDA Approves Once-Weekly GLP-1 Diabetes Treatment Regimen for T2DM
Posted September 25, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Are your patients getting enough glucose strips to manage their diabetes?
CME/CE of the Week
Hope Warshaw, MMSc, RD, CDE

Category: Nutrition
Credits: 1.25
Search Articles On Diabetes In Control